Stereotactic body radiation therapy in hepatocellular carcinoma: Optimal treatment strategies based on liver segmentation and functional hepatic reserve
- PMID: 26696781
- PMCID: PMC4661347
- DOI: 10.1016/j.rpor.2015.03.005
Stereotactic body radiation therapy in hepatocellular carcinoma: Optimal treatment strategies based on liver segmentation and functional hepatic reserve
Abstract
Aim: To discuss current dosage for stereotactic body radiation therapy (SBRT) in hepatocellular carcinoma (HCC) patients and suggest alternative treatment strategies according to liver segmentation as defined by the Couinaud classification.
Background: SBRT is a safe and effective alternative treatment for HCC patients who are unable to undergo liver ablation/resection. However, the SBRT fractionation schemes and treatment planning strategies are not well established.
Materials and methods: In this article, the latest developments and key findings from research studies exploring the efficacy of SBRT fractionation schemes for treatment of HCC are reviewed. Patients' characteristics, fractionation schemes, treatment outcomes and toxicities were compiled. Special attention was focused on SBRT fractionation approaches that take into consideration liver segmentation according to the Couinaud classification and functional hepatic reserve based on Child-Pugh (CP) liver cirrhosis classification.
Results: The most common SBRT fractionation schemes for HCC were 3 × 10-20 Gy, 4-6 × 8-10 Gy, and 10 × 5-5.5 Gy. Based on previous SBRT studies, and in consideration of tumor size and CP classification, we proposed 3 × 15-25 Gy for patients with tumor size <3 cm and adequate liver reserve (CP-A score 5), 5 × 10-12 Gy for patients with tumor sizes between 3 and 5 cm or inadequate liver reserve (CP-A score 6), and 10 × 5-5.5 Gy for patients with tumor size >5 cm or CP-B score.
Conclusions: Treatment schemes in SBRT for HCC vary according to liver segmentation and functional hepatic reserve. Further prospective studies may be necessary to identify the optimal dose of SBRT for HCC.
Keywords: Hepatitis B virus; Hepatocellular carcinoma; Segment; Stereotactic body radiation therapy.
Figures
![Fig. 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4661347/bin/gr1.gif)
![Fig. 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4661347/bin/gr2.gif)
Similar articles
-
Optimal hypofractionated radiation therapy schemes for early-stage hepatocellular carcinoma.Radiother Oncol. 2024 May;194:110223. doi: 10.1016/j.radonc.2024.110223. Epub 2024 Mar 11. Radiother Oncol. 2024. PMID: 38467342
-
Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma (HCC) With Single Photon Emission Computed Tomography (SPECT) Functional Treatment Planning in Patients With Advanced Hepatic Cirrhosis.Adv Radiat Oncol. 2023 Sep 1;9(2):101367. doi: 10.1016/j.adro.2023.101367. eCollection 2024 Feb. Adv Radiat Oncol. 2023. PMID: 38405302 Free PMC article.
-
Albumin-bilirubin score is a useful predictor of worsening liver reserve after stereotactic body radiation therapy in elderly Japanese patients with hepatocellular carcinoma.J Radiat Res. 2024 Mar 22;65(2):244-250. doi: 10.1093/jrr/rrae006. J Radiat Res. 2024. PMID: 38415344 Free PMC article.
-
Stereotactic body radiation therapy in primary hepatocellular carcinoma: current status and future directions.J Gastrointest Oncol. 2018 Oct;9(5):858-870. doi: 10.21037/jgo.2018.06.01. J Gastrointest Oncol. 2018. PMID: 30505586 Free PMC article. Review.
-
Stereotactic body radiation therapy for hepatocellular carcinoma: From infancy to ongoing maturity.JHEP Rep. 2022 May 14;4(8):100498. doi: 10.1016/j.jhepr.2022.100498. eCollection 2022 Aug. JHEP Rep. 2022. PMID: 35860434 Free PMC article. Review.
Cited by
-
Management of Hepatocellular Carcinoma in 2024: The Multidisciplinary Paradigm in an Evolving Treatment Landscape.Cancers (Basel). 2024 Feb 4;16(3):666. doi: 10.3390/cancers16030666. Cancers (Basel). 2024. PMID: 38339417 Free PMC article. Review.
-
Establishment of image-guided radiotherapy of orthotopic hepatocellular carcinoma mouse model.Animal Model Exp Med. 2023 Oct;6(5):419-426. doi: 10.1002/ame2.12335. Epub 2023 Jun 26. Animal Model Exp Med. 2023. PMID: 37365733 Free PMC article.
-
A human-in-the-loop based Bayesian network approach to improve imbalanced radiation outcomes prediction for hepatocellular cancer patients with stereotactic body radiotherapy.Front Oncol. 2022 Dec 9;12:1061024. doi: 10.3389/fonc.2022.1061024. eCollection 2022. Front Oncol. 2022. PMID: 36568208 Free PMC article.
-
Practical utility of liver segmentation methods in clinical surgeries and interventions.BMC Med Imaging. 2022 May 24;22(1):97. doi: 10.1186/s12880-022-00825-2. BMC Med Imaging. 2022. PMID: 35610600 Free PMC article.
-
Feasibility of SBRT for hepatocellular carcinoma in Brazil - a prospective pilot study.Rep Pract Oncol Radiother. 2021 Apr 14;26(2):226-236. doi: 10.5603/RPOR.a2021.0035. eCollection 2021. Rep Pract Oncol Radiother. 2021. PMID: 34211773 Free PMC article.
References
-
- Department of Health, Executive Yuan . 2014. Death Cause Statistics of 2010, Taiwan.http://www.doh.gov.tw/EN2006/DM/DM2.aspx?now_fod_list_no=10864 [accessed 01.05.14]
-
- Fong Z.V., Tanabe K.K. The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review. Cancer. 2014;120:2824–2838. - PubMed
-
- Llovet J.M., Fuster J., Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999;30:1434–1440. - PubMed
-
- Mazzaferro V., Regalia E., Doci R. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693–699. - PubMed
-
- Kuvshinoff B.W., Ota D.M. Radiofrequency ablation of liver tumors: influence of technique and tumor size. Surgery. 2002;132:605–611. [discussion 11-2] - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous